Submit your business proposal
日本語
About
Strategy
Team
Funds
Portfolio
News
Contact
Submit your business proposal
日本語
About
Strategy
Team
Funds
Portfolio
News
Contact
News
News type
Article
Event
Press release
Region
Japan
EU
Latest news
24th March 2023
Acticor Biotech publishes its 2022 annual results and provides an update on its clinical progress
Read more
22nd March 2023
Nikkei Bio Article: AMED's Drug Discovery Venture Ecosystem Enhancement Project Selected for the First Time by Two Companies - Edit Force and Immunohelix
Read more
22nd March 2023
EditForce, Inc. announced that our "Development of an Innovative Treatment for Myotonic Dystrophy Type 1 by a Sequence--Specific RNA Binding Protein Targeting Pathogenic CUG Repeat
Read more
22nd March 2023
EditForce, Inc. (Headquarter: Fukuoka, President and CEO: Takashi Ono) announces that we have raised a total of 1.8 billion yen through a third-party allotment of new shares by March 22, 2023.
Read more
9th March 2023
Acticor Biotech successfully completes a capital increase for a total gross amount of 12.2 million euros, via the issuance of 1,793,005 shares
Read more
7th March 2023
Sequana Medical announces positive results from CHIHUAHUA, Phase 1 clinical trial of second-generation DSR product for congestive heart failure
Read more
1st March 2023
Certified VC interview Newton Biocapital Partners Sadashi Suzuki by Medical Innovation Support Office (MEDISO) - Japanese Ministry of Health and Labour
Read more
8th February 2023
Sequana Medical announces the successful completion of pre-clinical studies with its second-generation DSR product for congestive heart failure
Read more
3rd February 2023
インタビュー記事掲載のお知らせ「2月3日の日経バイオテクに当社クリニカル & メディカル サイエンス・和田 道彦と、日本代表・鈴木 貞史の記事が掲載されました。タイトルは、「ベルギーNewton Biocapital社幹部に聞く、日本のシーズを世に出すには?」
Read more
1
2
3
Sign up
You are added to the list, thank you!